Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer

Completed · Phase 2

Conditions studied: Endometrial Cancer

In brief

RATIONALE: Drugs used in chemotherapy, such as oxaliplatin, work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of oxaliplatin in treating patients who have persistent or recurrent endometrial cancer.

Key facts

Study ID
NCT00071929
Run by
Gynecologic Oncology Group
Starts
1999-11-01
Expected to finish
2007-09-01
Last updated by the study team
2013-06-24

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.